AB Science (France) Investor Sentiment

AB Stock  EUR 1.36  0.03  2.16%   
About 62% of AB Science's investor base is looking to short. The analysis of current outlook of investing in AB Science SA suggests that many traders are alarmed regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
  
over three weeks ago at news.google.com         
Surgical Science Sweden Leads The Pack Of 3 Growth Stocks With Significant Insider Ownership - Yahoo...
Google News at Macroaxis
over a month ago at news.google.com         
Alzheimers Disease Therapeutics Market to Grow by USD 5.41 Billion , Novel Biomarker RD Boosts Growt...
Google News at Macroaxis
over two months ago at news.google.com         
Boston Scientific Co. Shares Acquired by Nordea Investment Management AB - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
AB Science adds 80m to market cap in the past 7 days, though investors from three years ago are stil...
Google News at Macroaxis
over three months ago at news.google.com         
Budweiser Parent AB InBev Stock Falls as Beer Volumes Decline - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
AB Science announces a slight delay in the publication of its 2024 half-year financial report - Yaho...
Google News at Macroaxis
over three months ago at news.google.com         
AB Science provides an update on the microtubule program AB89 and in particular the ability of AB89 ...
Google News at Macroaxis
over three months ago at news.google.com         
AB Science provides an update on the development of masitinib in progressive forms of multiple scler...
Google News at Macroaxis
over six months ago at news.google.com         
Allstate Sets New 12-Month High on Analyst Upgrade - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Integral Ad Science Holding Corp. CFO Sells 44,179.52 in Stock - American Banking and Market News
Google News at Macroaxis
over six months ago at news.google.com         
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19 - Yahoo ...
Google News at Macroaxis
over six months ago at news.google.com         
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimers drug - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
EMA takes negative view on masitinib Ocaliva, Translarna out - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Air Canada Short Interest Up 20.1 percent in June - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
MicroSectors U.S. Big Oil Index 3x Leveraged ETN Shares Gap Up to 492.88 - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AB Science that are available to investors today. That information is available publicly through AB Science media outlets and privately through word of mouth or via AB Science internal channels. However, regardless of the origin, that massive amount of AB Science data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AB Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AB Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AB Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AB Science alpha.

AB Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for AB Science Stock analysis

When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data